Fragile X Syndrome (FXS) Market Expected to Witness Significant Growth During the Forecast Period (2026-2036) Owing to Advancements in Disease-Modifying Therapies and Expanding Research Pipeline | DelveInsight

The Fragile X Syndrome (FXS) market is expected to witness significant growth across the 7MM during the forecast period (2026-2036), driven by increasing disease awareness, improvements in genetic diagnosis, growing research into disease-modifying therapies, and the anticipated launch of promising